Bodisen Biotech (LSE:BODI) Equity-to-Asset : 0.94 (As of Jun. 2013)

View and export this data going back to . Start your Free Trial

What is Bodisen Biotech Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Bodisen Biotech's Total Stockholders Equity for the quarter that ended in Jun. 2013 was £11.85 Mil. Bodisen Biotech's Total Assets for the quarter that ended in Jun. 2013 was £12.55 Mil. Therefore, Bodisen Biotech's Equity to Asset Ratio for the quarter that ended in Jun. 2013 was 0.94.

The historical rank and industry rank for Bodisen Biotech's Equity-to-Asset or its related term are showing as below:

LSE:BODI's Equity-to-Asset is not ranked ^*
in the Agriculture industry.
Industry Median: 0.52
* Ranked among companies with meaningful Equity-to-Asset only.

Bodisen Biotech Equity-to-Asset Historical Data

The historical data trend for Bodisen Biotech's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bodisen Biotech Equity-to-Asset Chart

Bodisen Biotech Annual Data

Trend

Dec03

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Equity-to-Asset

Get a 7-Day Free Trial

0.98

1.00

0.89

0.93

0.88

Bodisen Biotech Quarterly Data
	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Jun13
Equity-to-Asset	Get a 7-Day Free Trial															0.97	0.92	0.90	0.88	0.94

Competitive Comparison of Bodisen Biotech's Equity-to-Asset

For the Agricultural Inputs subindustry, Bodisen Biotech's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bodisen Biotech's Equity-to-Asset Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Bodisen Biotech's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Bodisen Biotech's Equity-to-Asset falls into.

Bodisen Biotech Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Bodisen Biotech's Equity to Asset Ratio for the fiscal year that ended in Dec. 2012 is calculated as

Equity to Asset (A: Dec. 2012 )	=	Total Stockholders Equity	/	Total Assets
	=	12.322	/	14.048
	=	0.88

Bodisen Biotech's Equity to Asset Ratio for the quarter that ended in Jun. 2013 is calculated as

Equity to Asset (Q: Jun. 2013 )	=	Total Stockholders Equity	/	Total Assets
	=	11.852	/	12.549
	=	0.94

Bodisen Biotech (LSE:BODI) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Bodisen Biotech Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Bodisen Biotech's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.